Postoperative Outcomes Within an Enhanced Recovery After Bariatric Surgery Protocol
Launched by GRUPO ESPAÑOL DE REHABILITACIÓN MULTIMODAL · Mar 5, 2019
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
The results of this study will allow to identify, on the one hand, the type of patients presenting postoperative complications and, on the other hand, to identify those items of the ERAS protocols that are independently associated with a reduction in postoperative complications and hospital stay, which will allow to focus the perioperative efforts in those items that actually improve the postoperative outcomes.
Aim 1 will establish the number of patients developing predefined postoperative complications within 30 days of surgery in adult patients undergoing elective bariatric surgery with ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients (aged ≥18 years) undergoing elective bariatric surgery and by any approach (Includes surgery with laparoscopic, assisted laparoscopic approach or open approach) in a participating hospital during the 30-day cohort period with a planned overnight stay.
- Exclusion Criteria:
- • Patients undergoing emergency surgery
- • Endoscopic procedures
- • Patients under 18 years of age
- • Patients with previous bariatric surgery who undergo revision surgery
- • Patients who refuse to participate
About Grupo Español De Rehabilitación Multimodal
Grupo Español de Rehabilitación Multimodal is a leading clinical trial sponsor dedicated to advancing rehabilitation practices through innovative research and multidisciplinary approaches. Committed to enhancing patient outcomes, the organization focuses on developing and implementing evidence-based rehabilitation strategies across various medical conditions. By fostering collaboration among healthcare professionals, researchers, and institutions, Grupo Español de Rehabilitación Multimodal aims to contribute significantly to the field of rehabilitation, ensuring that clinical trials are conducted with the highest standards of ethics and scientific rigor.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Madrid, , Spain
Madrid, , Spain
Ciudad Real, , Spain
Madrid, , Spain
Valencia, , Spain
Sevilla, , Spain
Valencia, , Spain
Zaragoza, , Spain
Madrid, , Spain
Santander, , Spain
Valladolid, , Spain
Guadalajara, , Spain
Madrid, , Spain
Oviedo, Asturias, Spain
Madrid, , Spain
Madrid, , Spain
Toledo, , Spain
Elche, Alicante, Spain
Valladolid, , Spain
Marbella, Málaga, Spain
Alcalá De Henares, Madrid, Spain
Alcorcón, Madrid, Spain
Burgos, , Spain
Sevilla, , Spain
Fuenlabrada, Madrid, Spain
Getafe, Madrid, Spain
Majadahonda, Madrid, Spain
Las Palmas, , Spain
Alcoy, Alicante, Spain
Mérida, Badajoz, Spain
Sabadell, Barcelona, Spain
Sant Joan D'espi, Barcelona, Spain
Vic, Barcelona, Spain
Baracaldo, Bizkaia, Spain
Castellon De La Plana, Castellón, Spain
A Coruna, Coruña, Spain
Cadiz, Cádiz, Spain
Jerez De La Frontera, Cádiz, Spain
Mostoles, Madrid, Spain
Mostoles, Madrid, Spain
Pozuelo De Alarcon, Madrid, Spain
Torrejon De Ardoz, Madrid, Spain
Malaga, Málaga, Spain
Barcelona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Las Palmas De Gran Canaria, , Spain
Menorca, , Spain
Murcia, , Spain
Pontevedra, , Spain
Vitoria, , Spain
Zaragoza, , Spain
Patients applied
Trial Officials
Javier M Ripollés-Melchor
Study Chair
Infanta Leonor University Hospital, Madrid, Spain
Raquel M Sanchez Santos
Study Chair
Complejo Hospitalario Universitario de Vigo
José M Ramírez
Study Director
Lozano Blesa University Hospital, Zaragoza, Spain
Jaime Ruiz Tovar
Study Director
Hospital Universitario Rey Juan Carlos Móstoles, Spain
César Aldecoa
Study Director
Hospital Universitario Río Hortega, Valladolid, Spain
Carlos Ferrando-Ortolá
Study Director
Hospital Clinic of Barcelona
Ester Martín García-Almenta
Study Director
Hospital Universitario Clínico San Carlos, Madrid
Ane Abad-Motos
Study Director
Infanta Leonor University Hospital, Madrid, Spain
Alfredo Abad-Gurumeta
Study Director
Infanta Leonor University Hospital, Madrid, Spain
Alejandro Suárez de la Rica
Study Director
Hospital Universitario La Paz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials